1996-2020年英格兰原发性骨肉瘤发病与生存趋势:国家疾病登记服务分析
该研究基于英格兰国家癌症登记数据集,纳入1996-2020年诊断的12,282例原发性骨肉瘤患者(年均491例),分析年龄别发病率、年龄标准化发病率及5年相对生存率。结果显示总体发病率变化不大,但软骨肉瘤和脊索瘤发病率上升、骨肉瘤下降;全部原发性骨肉瘤5年相对生存率从1998-2002年的52%提高至2013-2017年的65%,软骨肉瘤、脊索瘤和骨肉瘤的生存改善显著。
要点
- 全部原发性骨肉瘤5年相对生存率从1998-2002年的52%升至2013-2017年的65%。
- 软骨肉瘤(31%)和骨肉瘤(28%)是最常见的组织学亚型,脊索瘤发病率上升。
- 年轻、女性和四肢原发部位在多个亚型中与更好的生存相关。
核心结论
- 尽管原发性骨肉瘤罕见且异质,英格兰总体及多个临床重要亚组的生存均有改善,为国际比较和肉瘤服务评估提供基准。
研究设计与样本
- 基于英格兰国家癌症登记数据集的人群为基础分析,纳入1996-2020年诊断的原发性骨肉瘤患者12,282例(年均491例)。
主要发现
- 软骨肉瘤占31%、骨肉瘤占28%,为最常见亚型;总体发病率变化不大,但软骨肉瘤和脊索瘤发病率上升、骨肉瘤下降。
- 全部原发性骨肉瘤5年相对生存率从1998-2002年的52%提高至2013-2017年的65%。
- 软骨肉瘤、脊索瘤和骨肉瘤的生存改善显著;尤文肉瘤中骨盆肿瘤患者的生存改善尤为明显。
- 调整已测量病例组合后生存改善仍然明显;年轻、女性和四肢原发部位在多个亚型中与更好生存相关。
临床怎么用
- 该人群为基础数据可作为英格兰原发性骨肉瘤发病与生存的当代基准,用于国际比较和肉瘤服务与结局的持续评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Population-based studies detailing the incidence and survival of patients with primary bone sarcomas (PBS) are limited and often group morphologies and primary sites together. We examined incidence and outcomes for PBS in England and evaluated changes over time, within and across groups. METHODS: All patients diagnosed with PBS in England between 1996 and 2020 were identified from the National Cancer Registration Dataset. Age-specific incidence rates and five-year average age-standardised incidence rates (ASRs) were calculated using the 2013 European Standard Population. Five-year relative survival (RS) was estimated by diagnosis period, histological subtype and patient subgroup. Excess mortality models were used to assess survival trends over time. RESULTS: Between 1996 and 2020, 12,282 patients were diagnosed with PBS (mean 491 annually). Chondrosarcoma (31%) and osteosarcoma (28%) were the most common subtypes. Overall PBS incidence changed little over the study period; however, incidence increased for chondrosarcoma and chordoma and decreased for osteosarcoma. Five-year RS for all PBS improved from 52% in 1998-2002-65% in 2013-2017. Significant survival improvements were observed for chondrosarcoma, chordoma and osteosarcoma. In Ewing sarcoma, survival improved particularly among patients with pelvic tumours. Improvements remained evident after adjustment for measured case mix. Younger age, female sex and extremity primary site were associated with better survival in several subtypes. CONCLUSIONS: This national population-based analysis provides contemporary estimates of PBS incidence and survival in England. Despite the rarity and heterogeneity of these tumours, survival improved for PBS overall and for several clinically important patient subgroups. These findings provide an important benchmark for international comparisons and ongoing evaluation of sarcoma services and outcomes.
引用
- Hastings RA, Bacon A, Vinader V, et al. Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service. Eur J Cancer. 2026. PMID: 42628139. doi:10.1016/j.ejca.2026.116981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。